- Home
- SYBT vs NXPLW Comparison
SYBT vs NXPLW Comparison
Compare SYBT & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBT
- NXPLW
- Stock Information
- Founded
- SYBT 1904
- NXPLW N/A
- Country
- SYBT United States
- NXPLW United States
- Employees
- SYBT N/A
- NXPLW 166
- Industry
- SYBT Major Banks
- NXPLW Telecommunications Equipment
- Sector
- SYBT Finance
- NXPLW Telecommunications
- Exchange
- SYBT Nasdaq
- NXPLW Nasdaq
- Market Cap
- SYBT N/A
- NXPLW N/A
- IPO Year
- SYBT N/A
- NXPLW N/A
- Fundamental
- Price
- SYBT $68.93
- NXPLW $0.23
- Analyst Decision
- SYBT Hold
- NXPLW
- Analyst Count
- SYBT 3
- NXPLW 0
- Target Price
- SYBT $69.67
- NXPLW N/A
- AVG Volume (30 Days)
- SYBT 93.9K
- NXPLW 6.4K
- Earning Date
- SYBT 04-23-2025
- NXPLW 03-31-2025
- Dividend Yield
- SYBT 1.80%
- NXPLW N/A
- EPS Growth
- SYBT 6.00
- NXPLW N/A
- EPS
- SYBT 3.89
- NXPLW N/A
- Revenue
- SYBT $342,545,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- SYBT $14.27
- NXPLW N/A
- Revenue Next Year
- SYBT $5.94
- NXPLW N/A
- P/E Ratio
- SYBT $17.75
- NXPLW N/A
- Revenue Growth
- SYBT 5.57
- NXPLW 179.89
- 52 Week Low
- SYBT $42.35
- NXPLW $0.25
- 52 Week High
- SYBT $79.79
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- SYBT 43.34
- NXPLW N/A
- Support Level
- SYBT $67.60
- NXPLW N/A
- Resistance Level
- SYBT $71.71
- NXPLW N/A
- Average True Range (ATR)
- SYBT 1.51
- NXPLW 0.00
- MACD
- SYBT 0.15
- NXPLW 0.00
- Stochastic Oscillator
- SYBT 37.15
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.